Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent. | Front Immunol | 2022 | 36189296 | PubTator, text mining | PubMed |
| Nucleophosmin 1 is a prognostic marker of gastrointestinal cancer and is associated with m6A and cuproptosis. | Front Pharmacol | 2022 | 36188614 | PubTator, text mining | PubMed |
| Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy. | Comput Struct Biotechnol J | 2022 | 36187919 | PubTator, text mining | PubMed |
| Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma. | JHEP Rep | 2022 | 36185575 | PubTator, text mining | PubMed |
| Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment. | Drug Dev Res | 2022 | 36184877 | PubTator, text mining | PubMed |
| RNA binding protein IGF2BP1 meditates oxidative stress-induced granulosa cell dysfunction by regulating MDM2 mRNA stability in an m6A-dependent manner. | Redox Biol | 2022 | 36182806 | PubTator, text mining | PubMed |
| T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all. | Cell Mol Immunol | 2022 | 36180781 | PubTator, text mining | PubMed |
| m6A RNA methylation regulator-related signatures exhibit good prognosis prediction ability for head and neck squamous cell carcinoma. | Sci Rep | 2022 | 36175504 | PubTator, text mining | PubMed |
| Modification of m6A mediates tissue immune microenvironment in calcific aortic valve disease. | Ann Transl Med | 2022 | 36172101 | PubTator, text mining | PubMed |
| The alternative splicing of intersectin 1 regulated by PTBP1 promotes human glioma progression. | Cell Death Dis | 2022 | 36171198 | PubTator, text mining | PubMed |
| The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. | Theranostics | 2022 | 36168628 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Identification of molecular patterns and diagnostic biomarkers in juvenile idiopathic arthritis based on the gene expression of m6A regulators. | Front Pediatr | 2022 | 36160781 | PubTator, text mining | PubMed |
| Long noncoding RNA ZNFX1-AS1 promotes the invasion and proliferation of gastric cancer cells by regulating LIN28 and CAPR1N1. | World J Gastroenterol | 2022 | 36160641 | PubTator, text mining | PubMed |
| METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. | Front Cell Dev Biol | 2022 | 36158188 | PubTator, text mining | PubMed |
| Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma. | J Immunol Res | 2022 | 36157883 | PubTator, text mining | PubMed |
| The role of RNA m6A methylation in lipid metabolism. | Front Endocrinol (Lausanne) | 2022 | 36157445 | PubTator, text mining | PubMed |
| Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma. | Front Cell Dev Biol | 2022 | 36147735 | PubTator, text mining | PubMed |
| Benchmarking DNA methylation analysis of 14 alignment algorithms for whole genome bisulfite sequencing in mammals. | Comput Struct Biotechnol J | 2022 | 36147684 | PubTator, text mining | PubMed |
| RBM15 condensates modulate m6A modification of STYK1 to promote tumorigenesis. | Comput Struct Biotechnol J | 2022 | 36147665 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=53